Narayana Hrudayalaya Limited

NSE NH.NS

Narayana Hrudayalaya Limited Price to Earnings Ratio (P/E) on January 14, 2025: 31.73

Narayana Hrudayalaya Limited Price to Earnings Ratio (P/E) is 31.73 on January 14, 2025, a -24.48% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
  • Narayana Hrudayalaya Limited 52-week high Price to Earnings Ratio (P/E) is 46.97 on February 14, 2024, which is 48.01% above the current Price to Earnings Ratio (P/E).
  • Narayana Hrudayalaya Limited 52-week low Price to Earnings Ratio (P/E) is 29.54 on May 29, 2024, which is -6.90% below the current Price to Earnings Ratio (P/E).
  • Narayana Hrudayalaya Limited average Price to Earnings Ratio (P/E) for the last 52 weeks is 34.39.
Key data
Date Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield
Market news
Loading...
NSE: NH.NS

Narayana Hrudayalaya Limited

CEO Dr. Emmanuel Rupert
IPO Date Jan. 6, 2016
Location India
Headquarters 261/A, Bommasandra Industrial Area
Employees 11,659
Sector Health Care
Industries
Description

Narayana Hrudayalaya Limited provides medical and healthcare services. The company operates and maintains hospitals, clinics, health centers, nursing homes, and other related activities. It offers services in various specialties, including cardiology, cardiac surgery, nephrology, urology, neurology, neuro-surgery, endocrinology, orthopedics, internal medicines, obstetrics, gynecology, pediatrics, neonatology, gastroenterology, and oncology. As of June 30, 2022, the company operated through a network of 19 owned/operated hospitals, 2 managed hospitals, 4 heart centers, and 18 clinics and information centers in India, as well as a hospital in the Cayman Islands. It also provides healthcare consultancy services, including licensing of ERP solutions. The company was incorporated in 2000 and is headquartered in Bengaluru, India.

Similar companies

LALPATHLAB.NS

Dr. Lal PathLabs Limited

USD 32.39

-1.98%

SYNGENE.NS

Syngene International Limited

USD 9.56

0.73%

THYROCARE.NS

Thyrocare Technologies Limited

USD 9.54

0.38%

ASTERDM.NS

Aster DM Healthcare Limited

USD 5.77

1.93%

JBCHEPHARM.NS

J. B. Chemicals & Pharmaceuticals Limited

USD 20.35

-1.23%

StockViz Staff

January 15, 2025

Any question? Send us an email